ABBOTT LABORATORIES (ABT) Income statement
Top 20 of 28 line items reported by ABT · 250+ in the full API →
ABBOTT LABORATORIES (ABT) · Income Statement
Consolidated Statements of Operations
Annual · In millions USD, except per-share data · Latest filed Feb 20, 2026 · FY ends Dec 31
| Fiscal Years Ended | |||||
|---|---|---|---|---|---|
FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | Trend | |
| Total Revenue | $44,328 | $41,950 | $40,109 | $43,653 | |
| Cost of Revenue | 19,319 | 18,706 | 17,975 | 19,142 | |
| Gross Profit | $25,009 | $23,244 | $22,134 | $24,511 | |
| Other Operating Expenses | 16,956 | 16,419 | 15,656 | 16,149 | |
| Total Operating Expenses | 36,275 | 35,125 | 33,631 | 35,291 | |
| Operating Income | $8,053 | $6,825 | $6,478 | $8,362 | |
| EBIT (Earnings Before Interest & Tax) | 8,053 | 6,825 | 6,478 | 8,362 | |
| Add: Depreciation & Amortization | 3,116 | 3,218 | 3,243 | 3,267 | |
| EBITDA (Non-GAAP) | $11,169 | $10,043 | $9,721 | $11,629 | |
| Interest Income | 308 | 344 | 385 | 183 | |
| Interest Expense | -493 | -559 | -637 | -558 | |
| Foreign Exchange Gain (Loss) | 50 | 27 | (41) | (2) | |
| Non-Operating Income (Expense) | $(135) | $(188) | $(293) | $(377) | |
| Income Before Taxes (EBT) | $8,466 | $7,013 | $6,664 | $8,306 | |
| Provision for Income Taxes | 1,942 | (6,389) | 941 | 1,373 | |
| Effective Tax Rate | 22.9% | (91.1%) | 14.1% | 16.5% | |
| Net Income | $6,524 | $13,402 | $5,723 | $6,933 | |
| Shares Outstanding | 1,741 | 1,740 | 1,740 | 1,753 | |
| Diluted Earnings Per Share | $3.72 | $7.64 | $3.26 | $3.91 | |
| Gross Margin | 56.4% | 55.4% | 55.2% | 56.1% | |
8 more line items available via the API
Research & DevelopmentSales, General & AdministrativeAsset Impairment ChargesDiluted Shares OutstandingBasic Earnings Per ShareOperating MarginOther OpEx MarginNet Margin
Ask your agent:
get_financialsAPIGET /api/v1/companies/ABT/income-statement?period=annual&years=8Docs →